miR-198 represses the proliferation of HaCaT cells by targeting cyclin D2

International Journal of Molecular Sciences

Volumn 16, Issue 8, 2015, Pages 17018-17028

  Wang, Jian ^a   Dan, Guorong ^a   Shangguan, Tao ^a   Hao, Han ^a   Tang, Ran ^a   Peng, Kaige ^a   Zhao, Jiqing ^a   Sun, Huiqin ^a   Zou, Zhongmin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Cyclin D2; HaCaT; miR 198

Indexed keywords

CYCLIN D2; MICRORNA; MIR 198; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CCND2 PROTEIN, HUMAN; LUCIFERASE; MESSENGER RNA; MIRN198 MICRORNA, HUMAN; PROTEIN BINDING;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; CELL CYCLE G1 PHASE; CELL LINE; CYTOLOGY; ENZYME ASSAY; GENETICS; KERATINOCYTE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; CYCLIN D2; ENZYME ASSAYS; G1 PHASE; HUMANS; KERATINOCYTES; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84938092980     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160817018     Document Type: Article

References (29)

1. Ambros, V. The functions of animal micrornas. Nature 2004, 431, 350–355.
2. Esteller, M. Non-coding rnas in human disease. Nat. Rev. Genet. 2011, 12, 861–874.
3. Elfimova, N.; Noetel, A.; Varnholt, H.; Riemer, J.; Kwiecinski, M.; Quasdorff, M.J.; Dienes, H.P.; Odenthal, M. The role of tumor suppressor microRNAs in hepatocellular carcinoma. Hepatology 2009, 50, doi:10.1158/1538-7445.
4. Elfimova, N.; Sievers, E.; Eischeid, H.; Kwiecinski, M.; Noetel, A.; Hunt, H.; Becker, D.; Frommolt, P.; Quasdorff, M.; Steffen, H.M. et al. Control of mitogenic and motogenic pathwaysby miR-198, diminishing hepatoma cell growth and migration. Biochim. Biophys. Acta Mol.Cell Res. 2013, 1833, 1190–1198.
5. Chonglei, B.; Zhou, J.; Chung, T.H.; Huang, G.; Yan, J.; Chng, W.J. Identification of tumor suppressive microRNAs in multiple myeloma by pharmacologic unmasking. Clin. Lymphoma Myeloma Leuk. 2013, 13, S37–S38.
6. Ogunwobi, O.O.; Li, J.; Zhao, X.; Trevino, J.; George, T.; Liu, C. MiR-198 silencing is a mechanism of gemcitabine resistance in human pancreatic adenocarcinoma. Cancer Res. 2013, 73, doi:10.1158/1538-7445.
7. Wang, M.; Wang, J.; Kong, X.; Chen, H.; Wang, Y.; Qin, M.; Lin, Y.; Xu, J.; Hong, J.; Chen, Y.X. et al. MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci. Rep. 2014, 4, doi:10.1038/srep06145.
8. Wang, M.Y.; Wang, J.L.; Chen, H.M.; Fang, J.Y. MicroRNA-198 regulates elf3 expression and inhibits cell proliferation in colorectal cancer. Tumor 2014, 34, 494–500.
9. Yang, J.; Zhao, H.; Xin, Y.; Fan, L. MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting fgfr1. J. Cell. Biochem. 2014, 115, 987–995.
10. Sundaram, G.M.; Common, J.E.A.; Gopal, F.E.; Srikanta, S.; Lakshman, K.; Lunny, D.P.; Lim, T.C.; Tanavde, V.; Lane, E.B.; Sampath, P. “See-saw” expression of microRNA-198 and Fstl1 from a single transcript in wound healing. Nature 2013, 494, 103–106.
11. Sherr, C.J.; Roberts, J.M. Living with or without cyclins and cyclin-dependent kinases. Gene Dev. 2004, 18, 2699–2711.
12. Sherr, C.J. Cancer cell cycles. Science 1996, 274, 1672–1677.
13. Ando, K.; Ajchenbaum-Cymbalista, F.; Griffin, J.D. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc. Natl. Acad. Sci. USA 1993, 90, 9571–9575.
14. Liu, N.; Bezprozvannaya, S.; Williams, A.H.; Qi, X.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008, 22, 3242–3254.
15. Kota, J.; Chivukula, R.R.; O'Donnell, K.A.; Wentzel, E.A.; Montgomery, C.L.; Hwang, H.W.; Chang, T.C.; Vivekanandan, P.; Torbenson, M.; Clark, K.R. et al. Therapeutic microrna delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137, 1005–1017.
16. Yadav, S.; Pandey, A.; Shukla, A.; Talwelkar, S.S.; Kumar, A.; Pant, A.B.; Parmar, D. MiR-497 and miR-302b regulate ethanol-induced neuronal cell death through bcl2 protein and cyclin D2. J. Biol. Chem. 2011, 286, 37347–37357.
17. Ekhteraei Tousi, S.; Soltani, B.; Soleimani, M.; Sadeghizadeh, M.; Mowla, S.J. Potential involvement of Hsa-miR-133b in cardiomyocytes differentiation and proliferation. Cell J. 2012, 14, 35.
18. Li, L.; Sarver, A.L.; Alamgir, S.; Subramanian, S. Downregulation of microRNAs miR-1, -206 and -29 stabilizes pax3 and ccnd2 expression in rhabdomyosarcoma. Lab. Investig. 2012, 92, 571–583.
19. Mussnich, P.; D'Angelo, D.; Leone, V.; Croce, C.M.; Fusco, A. The high mobility group a proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression. Mol. Oncol. 2013, 7, 531–542.
20. Hutvagner, G.; Zamore, P.D. A microRNA in a multiple-turnover rnai enzyme complex. Science 2002, 297, 2056–2060.
21. Hutvagner, G.; Zamore, P.D. RNAi: Nature abhors a double-strand. Curr. Opin. Genet. Dev. 2002, 12, 225–232.
22. Nikiforova, M.N.; Dipaola, J.E.; Aspden, L.M.; Nikiforov, Y.E. MiRNA markers of aggressive behavior of papillary thyroid carcinoma. Lab. Investig. 2009, 89, 118A.
23. Lulla, R.R.; Costa, F.F.; Bischof, J.M.; Chou, P.M.; Bonaldo, M.D.F.; Vanin, E.F.; Soares, M.B. Identification of differentially expressed micrornas in osteosarcoma. Sarcoma 2011, 2011, doi:10.1155/2011/732690.
24. Tan, S.; Li, R.; Ding, K.; Lobie, P.E.; Zhu, T. MiR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett. 2011, 585, 2229–2234.
25. Marin-Muller, C.; Li, D.; Bharadwaj, U.; Li, M.; Chen, C.; Hodges, S.E.; Fisher, W.E.; Mo, Q.; Hung, M.C.; Yao, Q. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin. Cancer Res. 2013, 19, 5901–5913.
26. Ye, L.; Li, S.; Ye, D.; Yang, D.; Yue, F.; Guo, Y.; Chen, X.; Chen, F.; Zhang, J.; Song, X. Livin expression may be regulated by miR-198 in human prostate cancer cell lines. Eur. J. Cancer 2013, 49, 734–740.
27. Wong, T.S.; Liu, X.B.; Wong, B.Y.H.; Ng, R.W.M.; Yuen, A.P.W.; Wei, W.I. Mature miR-184 as potential oncogenic microrna of squamous cell carcinoma of tongue. Clin.Cancer Res. 2008, 14, 2588–2592.
28. Zhao, J.J.; Yang, J.; Lin, J.; Yao, N.; Zhu, Y.; Zheng, J.; Xu, J.; Cheng, J.Q.; Lin, J.Y.; Ma, X. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv. Syst. 2009, 25, 13–20.
29. Walter, B.A.; Valera, V.A.; Pinto, P.A.; Merino, M.J. Comprehensive microrna profiling of prostate cancer. J. Cancer 2013, 4, 350–357.